C620F
Showing 1 - 25 of >10,000
[18F]Florbetazine for Beta Amyloid PET Imaging in Alzheimer's
Recruiting
- Alzheimer's Disease
- [18F]Florbetazine ([18F]92)
- [11C]PIB
-
Beijing, ChinaDepartment of Nuclear Medicine, Peking Union Medical College Hop
Nov 19, 2023
Breast Cancer, Neuroendocrine Tumors, Neuroendocrine Carcinoma Trial in Copenhagen (18F-FDG, Injection of hyperpolarized
Enrolling by invitation
- Breast Cancer
- +3 more
- 18F-FDG
- +2 more
-
Copenhagen, DenmarkRigshospitalet
Jan 18, 2023
Healthy Trial in Cairo (Gleptomet 50/1000(Metformin HCl & Sitagliptin), Janumet 50/1000(Metformin HCl & Sitagliptin))
Completed
- Healthy
- Gleptomet 50/1000(Metformin HCl & Sitagliptin)
- Janumet 50/1000(Metformin HCl & Sitagliptin)
-
Cairo, EgyptGenuine Research Center GRC
Mar 22, 2023
Alzheimer Trial in Canada, United States (18F-Flortaucipir radiopharmaceutical, 18F-MK-6240 radiopharmaceutical, Amyloid-ß
Recruiting
- Alzheimer Disease
- 18F-Flortaucipir radiopharmaceutical
- +2 more
-
Berkeley, California
- +7 more
Jan 23, 2023
Mild Cognitive Impairment Trial in Winston-Salem ([11C]Acetoacetate[18F]Fluorodeoxyglucose positron emission tomography scan)
Enrolling by invitation
- Mild Cognitive Impairment
- [11C]Acetoacetate[18F]Fluorodeoxyglucose positron emission tomography scan
-
Winston-Salem, North CarolinaWake Forest School of Medicine
Dec 22, 2022
Comparison Between [11C]UCB-J and [18F]SynVest-1 PET in HD.
Not yet recruiting
- Huntington Disease
- [11C]UCB-J
- [18F]SynVest-1
-
Leuven, BelgiumUZ Leuven
Nov 2, 2022
Alzheimer Trial in Lille, Paris, Rouen ([11C]-UCB-J, [18F]-DPA-714, [18F]-RO-948)
Not yet recruiting
- Alzheimer Disease
- [11C]-UCB-J
- +3 more
-
Lille, France
- +2 more
Jun 12, 2023
Healthy Volunteers Trial in Nottingham ([14C]-GDC-9545, GDC-9545 Solution for Infusion, GDC-9545/F12 Capsule)
Completed
- Healthy Volunteers
- [14C]-GDC-9545
- +3 more
-
Nottingham, United KingdomQuotient Sciences
Jan 17, 2023
18F-fluorocholine, Positron-Emission Tomography, Hyperparathyroidism, Primary Trial in Toronto ([F-18]-FCH PET/MRI)
Active, not recruiting
- 18F-fluorocholine
- +2 more
- [F-18]-FCH PET/MRI
-
Toronto, Ont, CanadaUHN
Dec 9, 2022
Healthy Subjects, Cardiovascular Disease Trial (18F-FDG, 11C-butanol)
Not yet recruiting
- Healthy Subjects
- Cardiovascular Disease
- (no location specified)
Aug 22, 2023
Lesion With Known or Suspected F-choline Uptake Trial in Montréal (F-choline intravenous injection)
Recruiting
- Lesion With Known or Suspected F-choline Uptake
- F-choline intravenous injection
-
Montréal, Quebec, CanadaCentre Hospitalier de l'université de Montréal
Dec 6, 2022
Peripheral Analgesic and Anti-itch Trial in Suzhou ([14C]HSK21542)
Completed
- Peripheral Analgesic and Anti-itch
-
Suzhou, Jiangsu, Chinaf the First Affiliated Hospital of soochow University
Apr 19, 2023
Cancer, Quality of Life Trial in Regensburg
Not yet recruiting
- Cancer
- Quality of Life
-
Regensburg, GermanyCenter for Clinical Studies, University Hospital Regensburg
Jul 28, 2022
Type 2 Diabetes Trial (ARM A, ARM B, ARM C)
Not yet recruiting
- Type 2 Diabetes
- ARM A
- +5 more
- (no location specified)
Dec 27, 2022
Functional Relevance of Dopamine Receptors in Healthy Controls
Recruiting
- Schizoaffective Disorder
- Schizophrenia
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022
Mild Cognitive Impairment Trial in Philadelphia (2-(2-([18F]fluoro)pyridin-4-yl)-9H-pyrrolo[2,3-b:4,5-c']dipyridine)
Recruiting
- Mild Cognitive Impairment
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania, School of Medicine
Dec 9, 2022
Nodular Lymphocyte Predominant Hodgkin Lymphoma, Recurrent Nodular Lymphocyte Predominant Hodgkin Lymphoma, Refractory Nodular
Not yet recruiting
- Nodular Lymphocyte Predominant Hodgkin Lymphoma
- +2 more
- Biopsy
- +9 more
- (no location specified)
Jun 1, 2023
Prostate Cancer Trial in New York (positron emission tomography, fludeoxyglucose F 18, methionine C 11)
Active, not recruiting
- Prostate Cancer
- positron emission tomography
- +2 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
May 18, 2022
Retinal Detachment Trial (Pars plana vitrectomy, Pars plana vitrectomy with scleral buckle, Sulfur hexafluoride gas tamponade)
Not yet recruiting
- Retinal Detachment
- Pars plana vitrectomy
- +3 more
- (no location specified)
May 16, 2023
Botulism Trial (A minimum of one 5 mL serum sample (up to three per enrolled subject) will be collected.)
Enrolling by invitation
- Botulism
- Blood sample collection
- (no location specified)
Jan 30, 2023
Presynaptic Imaging in Major Depressive Episodes After COVID-19
Recruiting
- Long COVID
- +2 more
- [11C]DTBZ PET scan
- +2 more
-
Toronto, Ontario, CanadaCentre for Addiction and Mental Health
Oct 15, 2023